Maxcyte (MXCT) Inventory Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Inventory Average data on file, last reported at $7.6 million in Q1 2026.

• On a quarterly basis, Inventory Average fell 11.69% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 11.69% decrease from a year earlier, with the FY2025 full-year figure at $8.2 million, down 22.14% from the prior year.
• Inventory Average for Q1 2026 stood at $7.6 million, roughly flat from $7.6 million in the prior quarter.
• Over the last five years, Inventory Average for MXCT reached as high as $12.4 million in Q4 2023 and fell as low as $5.9 million in Q1 2022.
• Historically, Inventory Average has averaged $9.2 million across 5 years, with a median of $8.6 million in 2025.
• Across the five-year window, Inventory Average jumped 87.95% in 2022 and fell 29.9% in 2025, its largest moves.
• Year by year, Inventory Average stood at $8.2 million in 2022, then jumped by 50.14% to $12.4 million in 2023, then decreased by 22.03% to $9.7 million in 2024, then dropped by 21.49% to $7.6 million in 2025, then grew by 0.13% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $7.6 million in Q1 2026, $7.6 million in Q4 2025, and $7.8 million in Q3 2025.